Mark Christopher Coles

10.9k citations
148 papers · 8.3k · 3 hit papers · h-index 46

Impact in

  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • IL-33, ST2, and ILC Pathways
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Immune Response and Inflammation
  • Oncology top 2%
    • CAR-T cell therapy research

Papers in

    • Immune Cell Function and Interaction 45
    • T-cell and B-cell Immunology 37
    • Immunotherapy and Immune Responses 32
    • IL-33, ST2, and ILC Pathways 15
    • Immune cells in cancer 9
    • CAR-T cell therapy research 10

Mark Christopher Coles

143 papers receiving 8.2k citations

Mark Christopher Coles's Hit Papers

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity 2022 · 209 citations
2090+2+4Years since publication200400600

Peers

Mark Christopher Coles
Comparison fields: 5 of 170
  • Immunology 4.2k
  • Oncology 1.4k
  • Hematology 485
  • Rheumatology 567
  • Genetics 308
Replace Birgit Sawitzki with:
Birgit Sawitzki Germany
Philip D. Hodgkin Australia
Lauri J. Diehl United States
Tri Giang Phan Australia
Annamari Ranki Finland
Richard J. Cornall United Kingdom
Dimitry M. Danilenko United States
Kaan Boztuǧ Austria
Andrew D. Wells United States
Cosima T. Baldari Italy
Mark Christopher Coles relative to Birgit Sawitzki Germany Birgit Sawitzki's profile →
Citations per field
00.5×1.5×
Birgit Sawitzki · 1×
Citations per year

Countries citing papers authored by Mark Christopher Coles

Since Specialization
Citations

This map shows the geographic impact of Mark Christopher Coles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Christopher Coles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Christopher Coles more than expected).

Fields of papers citing papers by Mark Christopher Coles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Christopher Coles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Christopher Coles. The network helps show where Mark Christopher Coles may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Christopher Coles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Christopher Coles Line = papers co-authored together Mark Christopher Coles links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Distinct fibroblast subsets drive inflammation and damage in arthritis
Hit paper breakdown →
2019738
2 2003626
3
Fibroblasts as immune regulators in infection, inflammation and cancer
Hit paper breakdown →
2021440
4 2009371
5 2007239
6 2014215
7 2021211
8
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Hit paper breakdown →
2022209
9 2000180
10 2019171
11 2015162
12 2022158
13 2015152
14 2009151
15 2008151
16 1993146
17 2014144
18 1994142
19 2004139
20 2012136

About Mark Christopher Coles

Mark Christopher Coles is a scholar working on Immunology, Oncology, Molecular Biology, Hematology and Genetics, having authored 148 papers that have together received 8.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (45 papers), T-cell and B-cell Immunology (37 papers), Immunotherapy and Immune Responses (32 papers), IL-33, ST2, and ILC Pathways (15 papers), CAR-T cell therapy research (10 papers), Gene Regulatory Network Analysis (9 papers), Immune cells in cancer (9 papers) and Single-cell and spatial transcriptomics (9 papers). The work is most often cited by research in Immunology (4.2k citations), Oncology (1.4k citations), Hematology (485 citations), Rheumatology (567 citations) and Genetics (308 citations). Mark Christopher Coles has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include David H. Raulet, Dimitris Kioussis, Henrique Veiga‐Fernandes, Jasper de Boer, Christopher Dominic Buckley, Trisha Norton, Paul Martin Kaye, Adam Williams, Kathleen Roderick and Mauro Tolaini. Their work appears in journals such as Frontiers in Immunology, The Journal of Immunology, The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact